Yissum - Research Development Company of the Hebrew University

Cannabinoid-based Drugs for Preventing Age-Related Osteoarthritis

Posted by Yissum - Research Development Company of the Hebrew UniversityResponsive · Innovative Products and Technologies · Israel

Summary of the technology

Cannabinoid-based Drugs for Preventing Age-Related Osteoarthritis
Project ID : 46-2019-10768

Description of the technology

Cannabinoid-Based Drugs for Preventing Age-Related Osteoarthritis Mona Dvir Ginzberg

Degenerative diseases become prominent with progressive ageing and thus present the most urgent biomedical challenge facing developed countries to date. One of the most prevalent musculoskeletal diseases caused during aging Osteoarthritis (OA), which is widely studied in Dr. Dvir-Ginzberg’s lab.

OA is characterized by progressive and irreversible erosion of articular cartilage. Progressive erosion of articular cartilage first leads to painful movements and ultimately causes loss of mobility, which has severe individual and socio-economic consequences. Age-related osteoarthritis is evident in over 30% of senior citizen. The number of osteoarthritic patients keeps increasing due to the increased life expectancy and obesity pandemic in our western societies. This is all the more alarming that there is currently no effective treatment for the disease, besides joint replacement. This procedure, however, is far from being ideal, as it requires major surgery, which is highly risky in the elderly. Moreover, prosthetic joints have a shelf life shorter than 20 years and contain titanium and other substances that can cause cancer, which is a major concerns for servicemen and other young individuals. There is thus an urgent need for novel therapeutics to prevent OA in individuals at risk, and to effectively halt the devastating symptoms of OA, which is the main objective of the research under this project. Specifically, Dr. Dvir-Ginzberg’s lab is interested in investigating the role of cannabinoids in preventing cartilage erosion and joint inflammation. To this end, we will administer cannabinoids systemically and locally (i.e to the joint space) and monitor its effect on pain and joint erosion in preclinical murine models. We hope that these experiments will provide a foundation for future clinical studies, for the benefit and sustained quality of life of our aging populations.

Project manager

Mel Larrosa
VP Business Development Healthcare

Project researchers

Mona Dvir-Ginzberg
HUJI, Faculty of Dental Medicine
Institute of Dental Sciences

Related keywords

  • Medicine, Human Health
  • Biology / Biotechnology
  • Genome Research
  • Micro- and Nanotechnology related to Biological sciences
  • Recombinant DNA
  • Monoclonal Antibodies and Hybridomas
  • Gene Splicing and Manufacturing Equipment
  • Other Genetic Engineering
  • Molecular design Market
  • Microbiology Market
  • Micro- and Nanotechnology related to Biological sciences
  • Biochemistry / Biophysics Market
  • Toxicology Market
  • In vitro Testing, Trials Market
  • Stem cells and biobanks
  • Cellular and Molecular Biology Market
  • Population genetics Market
  • Gene Expression, Proteom Research Market
  • Bioinformatics Market
  • Enzymology/Protein Engineering/Fermentation
  • Genetic Engineering Market
  • Diagnostic
  • Therapeutic
  • Other Medical/Health Related
  • Agro and Marine biotech
  • Anatomy, Pathology, Immunology, Physiology
  • Clinical Medicine
  • Life Science & Biotechnology

About Yissum - Research Development Company of the Hebrew University

Technology Transfer Office from Israel

Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Founded in 1964 to protect and commercialize the Hebrew University’s intellectual property. Ranked among the top technology transfer companies, Yissum has registered over 8,900 patents covering 2,500 inventions; has licensed out 800 technologies and has spun-off 90 companies. Products that are based on Hebrew University technologies and were commercialized by Yissum generate today over $2 Billion in annual sales.

Send your request

By clicking "Send your request" you are signing up and accepting our Terms of Service and Privacy policy

Technology Offers on Innoget are directly posted and managed by its members as well as evaluation of requests for information. Innoget is the trusted open innovation and science network aimed at directly connect industry needs with professionals online.